Format

Send to

Choose Destination
Crit Rev Oncol Hematol. 2012 Oct;84(1):1-7. doi: 10.1016/j.critrevonc.2012.02.009. Epub 2012 Mar 18.

Metabolomics in cancer: a bench-to-bedside intersection.

Author information

1
Department of Internal Medicine, Wayne State University School of Medicine, Detroit, MI 48201, USA.

Abstract

The field of oncology is a rapidly evolving science mostly due to extensive basic, translational and clinical research which have provided more insights into the tumor biology and set grounds for the development of new therapies. Metabolomics is the upcoming new science in the omics field with the potential to further increment our knowledge of cancer biology. In this review we intend to explore the potential role of metabolomics in understanding cancer process, improving cancer staging, refining tumor characterization and in the search for predictive biomarkers of response and toxicity.

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center